Atherectomy devices are the medical devices, which are used for removing atherosclerosis from blood vessels within the body. Atherectomy devices are alternative to angioplasty and widely used to treat narrowing in arteries caused by peripheral artery disease. There are four types of atherectomy namely: Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy.
Increasing prevalence of cardiovascular diseases (CVD’s) is expected to drive growth of atherectomy devices market. According to article published in the European Heart Network (EHN) in 2017, CVD causes around 3.9 million deaths in Europe annually and over 1.8 million deaths in the European Union, which accounts for about 45% of all deaths in Europe and 37% of all deaths in the EU. Furthermore launches of innovative products and frequent approval of these devices from regulatory bodies is expected to drive growth of the atherectomy devices market. In 2018, Avinger Inc., received CE Marking approval for next-generation Pantheris Lumivascular atherectomy system, an image-guided atherectomy device for the treatment of Peripheral artery disease. Increasing adoption of novel product is expected to fuel growth of the global atherectomy devices market.
- This report provides in-depth analysis of atherectomy devices market and provides market size (USD Bn) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global atherectomy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global atherectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the atherectomy devices market
-
- Directional Atherectomy Devices
- Rotational Atherectomy Devices
- Orbital Atherectomy Devices
- Laser Atherectomy Devices
-
- Cardiovascular
- Neurovascular
- Peripheral Vascular
-
- Hospitals
- Ambulatory Surgical Centers
- Medical Institutes
-
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
-
- Medtronic plc
- Koninklijke Philips N.V.
- Cardiovascular Systems, Inc
- Boston Scientific Corporation
- Avinger, Inc
- R. Bard, Inc
- Cardinal Health, Inc.
- Minnetronix, Inc.
- Straub Medical AG
- Biotronik
